Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Finasteride may reduce prostate tumor cell invasion and spread.

New technologies show promise for better hair regeneration and treatments.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Finasteride-coated microneedles effectively deliver the drug with minimal scalp damage and high stability.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

New therapies are being developed that target integrin pathways to treat various diseases.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Certain drugs change freshwater snail shells to a "banana" shape.